The Qatari health authority announced the recall of all batches of Clasgen 0.05% eye drops in the country due to detected manufacturing defects.
The Ministry of Public Health (MoPH) reported that issues related to data integrity and sterile production processes were identified. These eye drops are prescription immunomodulatory agents intended for treating chronic dry eye (keratoconjunctivitis sicca) by reducing surface inflammation and promoting the restoration of natural tear production.
To ensure public safety, the health authority has issued multiple warnings and conducted product recalls. Last month, a warning was issued regarding the use of the weight loss product GastroZero Phyto Fiber Drink GastroKonjac, in which two undeclared pharmaceutical ingredients were found.
The ministry's drug quality control laboratory conducted tests and confirmed the presence of sibutramine and sildenafil, which were not listed in the product's composition. The Ministry warned that the presence of these undeclared pharmaceutical components renders the product substandard and may pose a threat to public health, as consumers could be exposed to potentially harmful substances without knowledge.
Such recall cases are not limited to this Gulf country. Last month, the UAE ordered the preventive recall of batch No. 20251015 of three-layer Nin 160 FMB-NML blue face masks due to quality issues. This recall followed a quality complaint and subsequent inspection results that revealed foreign material or contamination in units from the affected batch.
Recently, Dubai recalled certain batches of Babies’ Magic Tea – Baby Sleep Gripe Water due to the presence of undeclared alcohol and lack of a valid marketing authorization. The recall occurred after a circular issued by the Emirates Drug Authority (EDE), which notified clinics and healthcare professionals about the recall of batch number 25122bw of this 'baby health and safety' product. The Dubai Health Authority also disseminated this notification.
Just one day prior, residents of the UAE were advised to report any side effects they might experience after taking medication as part of a nationwide campaign aimed at enhancing medication safety.


